Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Q4 2025 Earnings Call Transcript March 19, 2026
Taysha Gene Therapies, Inc. beats earnings expectations. Reported EPS is $-0.08711, expectations were $-0.09561.
Operator: Good day, and thank you for standing by. Welcome to the Taysha Gene Therapies, Inc.’s full-year 2025 financial results conference call. At this time, participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. You would...
